Mencari ubat atas namanya

Zoloft (Sertraline Tablets) dan Penyakit hati

Hasil ujian interaksi ubat Zoloft (Sertraline Tablets) dan penyakit Penyakit hati untuk kontraindikasi dan kesan sampingan dengan penggunaan bersama.

Hasil pemeriksaan:

Zoloft (Sertraline Tablets) <> Penyakit hati

Relevan: 23.07.2019 Pengulas: MD P.M. Shkutko, in

Kontraindikasi atau kesan sampingan yang boleh membahayakan atau meningkatkan kesan negatif apabila menggunakan ubat dengan penyakit ditemui saat pemeriksaan interaksi mengikut sumber yang bereputasi - Drugs.com, RXList.com, Webmd.com, MedScape.com.

Pengguna:

Selektif reuptake inhibitor (Ssri) terutamanya kekal oleh hati. Plasma kepekatan Ssri dan mereka metabolik mungkin meningkat dan setengah hidup lama dalam pasien dengan gangguan fungsi hati. Dos penyesuaian yang perlu selaras dengan produk individu pakej pelabelan.

Sumber

Guthrie SK "Sertraline: a new specific serotonin reuptake blocker." DICP 25 (1991): 952-61
"Product Information. Celexa (citalopram)." Forest Pharmaceuticals, St. Louis, MO.
"Product Information. Zoloft (sertraline)." Roerig Division, New York, NY.
"Product Information. Luvox (fluvoxamine)." Solvay Pharmaceuticals Inc, Marietta, GA.
"Product Information. Paxil (paroxetine)." GlaxoSmithKline, Research Triangle Park, NC.
"Product Information. Prozac (fluoxetine)." Dista Products Company, Indianapolis, IN.
van Harten J "Clinical pharmacokinetics of selective serotonin reuptake inhibitors." Clin Pharmacokinet 24 (1993): 203-20
Krastev Z, Terziivanov D, Vlahov V, Maleev A, Greb WH, Eckl KM, Dierdorf HD, Wolf D "The pharmacokinetics of paroxetine in patients with liver cirrhosis." Acta Psychiatr Scand Suppl 350 (1989): 91-2
Wilde MI, Plosker GL, Benfield P "Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness." Drugs 46 (1993): 895-924
Doogan DP, Caillard V "Sertraline: a new antidepressant." J Clin Psychiatry 49 (1988): 46-51
Kaye CM, Haddock RE, Langley PF, Mellows G, Tasker TC, Zussman BD, Greb WH "A review of the metabolism and pharmacokinetics of paroxetine in man." Acta Psychiatr Scand Suppl 350 (1989): 60-75
Finley PR "Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions." Ann Pharmacother 28 (1994): 1359-69
"Product Information. Lexapro (escitalopram)." Forest Pharmaceuticals, St. Louis, MO.
Lund J, Thayssen P, Mengel H, Pedersen OL, Kristensen CB, Gram LF "Paroxetine: pharmacokinetics and cardiovascular effects after oral and intravenous single doses in man." Acta Pharmacol Toxicol (Copenh) 51 (1982): 351-7
Murdoch D, McTavish D "Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive- compulsive disorder." Drugs 44 (1992): 604-24
Benfield P, Ward A "Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness." Drugs 32 (1986): 313-34
Schenker S, Bergstrom RF, Wolen RL, Lemberger L "Fluoxetine disposition and elimination in cirrhosis." Clin Pharmacol Ther 44 (1988): 353-9